Latest Immune System / Vaccines News From Medical News Today.

Total news: 341
Last news: May 3, 2008 07:00:00

Continuing its 15-year tradition of recognizing extraordinary accomplishments and groundbreaking research in the field of vaccinology, Sabin Vaccine Institute (SVI) has announced Dr. Ruth S. Nussenzweig as the recipient of the 2008 Albert B. Sabin Gold Medal for her outstanding malaria-focused initiatives. SVI has also named Dr. - [Read more]

Haitis largest vaccination effort in history-aimed at more than 5 million children and youths-will be kicked off with a new public service announcement (PSA) featuring Haitian musician, producer and writer Wyclef Jean, a founding member of the ALAS Foundation. The PSA, produced by the Pan American Health Organization (PAHO) in association with ALAS, is aimed at boosting participation in the upcoming campaign to vaccinate young Haitians against measles and rubella. - [Read more]

Would tricyclic antidepressants help those with inflammatory bowel disease?It is thought that intestinal inflammatory conditions such as inflammatory bowel disease are exacerbated by depression. New data, generated by Stephen Collins and colleagues at McMaster University Medical Center, Canada, have characterized a mechanism by which experimental conditions that induced depressive-like behaviors in mice increased susceptibility to intestinal inflammation. - [Read more]

The US Centers for Disease Control and Prevention (CDC) reported yesterday that the rise in measles cases so far this year is mostly imported, due to infected people coming into the US from other countries. For the seven years up to 2007, an average of 62 cases of measles a year have been reported to the CDC. But this year, up to 25th April, a total of 64 cases, 54 of which are imported from countries outside the US, have been reported. - [Read more]

Performance testing for nasal delivery devices is one of the new services being offered by Melbourn Scientific. Although traditionally used for the local administration of decongestants and anti-histamines, the potential of a nasal route is now being investigated for a wide range of treatments from the instant relief of panic attacks through to needle-free vaccinations. This creates new challenges for devices and requires new testing regimes. - [Read more]

By pinpointing the window of opportunity when the human immune response to a particular pathogen peaks, scientists in the US have developed a much faster way to isolate the highly specific antibodies needed to make flu vaccines. The discovery may also lead to new and faster ways to produce vaccines and therapies to fight many other diseases. - [Read more]

The BVA has welcomed Defra Secretary of Sate Hilary Benns announcement on the arrival of the first batch of Bovilis® BTv8 vaccine in the UK. Congratulating Intervet on the speed with which the vaccine had been developed BVA President Nick Blayney said "this news represents a crucial stage in our fight against Bluetongue. - [Read more]

KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, announced that the company has completed dosing subjects in a U.S. Phase 1 clinical trial of its third drug candidate, KB003. The study is a placebo-controlled, single-dose, dose-escalation Phase 1 trial in healthy volunteers, with safety and immunogenicity as primary endpoints. - [Read more]

Scientists at Johns Hopkins have outlined a new path for potential therapies to combat inflammation associated with sinusitis and asthma based on a new understanding of the bodys earliest immune response in the nose and sinus cavities. - [Read more]

Your toddler might be improperly vaccinated, even if shes had every immunization the government recommends, according to a new study from the Centers for Disease Control and Prevention.More than one in four children are out of compliance with U.S. vaccination guidelines, say researchers led by Elizabeth Luman, Ph.D., of the National Center for Immunization and Respiratory Diseases. - [Read more]

DOR BioPharma, Inc. (OTCBB: DORB) ("DOR" or "The Company"), a late-stage biopharmaceutical company, announced the initiation of a comprehensive program to evaluate the efficacy of RiVax™ in non-human primates. RiVax™ is a recombinant subunit vaccine intended to protect humans against exposure to ricin toxin. - [Read more]

The Centers for Disease Control and Prevention (CDC) warns that over 20% of American 2-year-olds are not fully immunized against infectious diseases to which they are particularly susceptible. A joint venture between the CDC and HHS (US Department of Health and Human Services) has been reminding parents, caregivers and healthcare providers of the benefits of immunization, as well as the importance of routine childhood vaccination. Dr. - [Read more]

A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. In findings published in the online edition of the Proceedings of the National Academy of Sciences, the researchers report that they have blocked HIV infection in the test tube by inactivating a human protein expressed in key immune cells. - [Read more]

The IFPMA Influenza Vaccine Supply international task force (IFPMA IVS) will grant EUR 200,000 to the Pathogen Evolution Group1 at the University of Cambridge in the UK, to support computerized mapping of the H1N1 and B influenza viruses. The group, recently described as "mapmaker for the world of influenza"2, has already mapped the H3N2 influenza virus. - [Read more]

Thereis a simplified method of administering rabies vaccines that iseconomical and just as effective at stimulating anti-rabies antibodiesas the more expensive, standard vaccine regimen, according to anarticle published on April 23, 2008 in the open access journal PLoSNeglected Tropical Diseases. Deathsfrom rabies in humans are all the result of failure to administeradequate prophylaxis. - [Read more]

The recent failure of a Merck HIV/AIDS vaccine candidate was a "disappointment," but "failure is the rule" in vaccine and drug development, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a - [Read more]

Leading HIV/AIDS researchers in Britain and the U.S. are pessimistic about the prospects of developing an HIV vaccine following the recent failure of a Merck vaccine candidate, according to a survey conducted by Londons Independent, the - [Read more]

With a spirit of integration and Pan-Americanism, health authorities carried out launches and immunization activities in all countries and territories of the Americas this week, working to vaccinate 62 million children, young people and adults throughout the Region, including indigenous populations in border areas. - [Read more]

An immune cell known as a neutrophil releases a protein that can suppress glucose production in the liver - without targeting insulin, researchers have found.Neutrophils, a type of white blood cell, produce special immune proteins called defensins which seem to have a connection with glucose levels. During bacterial infection, defensin production can increase dramatically, a rise that frequently results in hypoglycemia. - [Read more]

Top vaccine experts and child advocates meeting in Barcelona hailed dramatic new evidence of the role of immunisation in reducing deaths among children in the worlds poorest nations."Each day, more and more children are being given life-saving vaccines. With higher immunisation rates, fewer of them are now dying of preventable infectious diseases," said Graça Machel, President of the Foundation for Community Development (FDC) for Mozambique. - [Read more]